Salim Yusuf is a Professor of Medicine and Clinical Epidemiology and Biostatistics at McMaster University and Director of the Population Health Research Institute. As a Rhodes Scholar, he initiated the concept of large simple trials, coordinating the first ISIS trial and developing concepts of meta-analysis. Subsequently, he has applied these principles to several other areas that led to the SOLVD and DIG trials in heart failure while at the US NIH, and more recently the HOPE, OASIS, CURE and CREATE trials since his move to McMaster University, Canada. He holds a Heart and Stroke Foundation ...

Professor of Medicine, Director, Leadership Sinai Centre for Diabetes. University of Toronto Dr. Bernard Zimnan is one of Canada's most distinguished clinician-scientists with exceptional achievements in Diabetes research and care. He has excelled as a physician researcher, educator, mentor and academic citizen. His most significant enduring initiative was his role in the NIH-directed Diabetes Control and Complications Trial (DCCT) and related follow-up studies, which established the importance of glycemic control in the preventing the complications of Type 1 Diabetes. As a translational ...

University of Toronto

Stanley H Zlotkin, MD PhD FRCP(C) is a highly respected and celebrated leader in the field of medicine, and specifically childhood nutrition. His work, as a Professor of Paediatrics at the University of Toronto and a senior scientist and gastroenterologist/clinical nutritionist, has attracted worldwide attention for its innovation and impact. Most importantly has been his development and dissemination of innovative and easy-to-use nutritional supplements, such as iron and vitamins, to address deficiencies which affect many children in the developing world. He has been able to translate his ...

Professor Emeritus, University of Alberta

Kue Young has played a pivotal role in the development of Aboriginal and northern health research in Canada and internationally. He was one of the first researchers in Canada to recognize the emerging diabetes epidemic among First Nations in the early 1980’s. He has contributed substantially to understanding the epidemiology and genetics of diabetes in that population, and its prevention and control. A population health research scientist of the first order, he received the CIHR Senior Investigator award 1998-2008. Dr. Young has authored six books on Aboriginal and circumpolar health, and a ...

Dr. Whiteside is an MD and PhD graduate ofthe University of Toronto and FRCP(C) in Internal Medicine and Nephrology. From1985 to 2005 she was a staff nephrologist at the University Health Network,Toronto, and clinician-scientist in the Department of Medicine. From 2000 to2005 she was Associate Dean Graduate and Inter-Faculty Affairs in the Facultyof Medicine and from 2006 to 2014 Dean of Medicine and Vice Provost Relationswith Health Care Institutions at the University of Toronto. In 2012 she wasrecognized with WXN Canada's Most Powerful Women Top 100 Award.Dr. Whiteside was awarded in 2007 ...

Professor and Director, Clinical Research Unit, University of Calgary

Dr. Wiebe is an internationally recognized clinical researcher focusing on neurosciences and epilepsy and in evidence based medicine. He specializes in surgical randomized controlled trials, and in patient-centred outcomes. He performed the only randomized trial on brain surgery for epilepsy, which resulted in international treatment guidelines for this condition. Dr. Wiebe has trained numerous clinical researchers, he leads national and international clinical research initiatives, and he plays a major role in establishing educational and clinical care programs in epilepsy around the world.

Professor and Head, Division of Gastroenterology, University of British Columbia; Head, Division of Gastroenterology, Vancouver General Hospital Dr. Eric Yoshida exemplifies the attributes required to be a leader and a key voice in discussions regarding ongoing health care delivery in Canada. Having been an integral component and the driving force behind the University of British Columbia's Hepatology Program, he has not only secured a reputable national profile for this department, but also, at the same time written numerous scholarly articles, and been an excellent mentor for the next ...

Faculty of Medicine Distinguished Research Chair, University of Ottawa

Dr. Phil Wells is a Hematologist. He is currently a University of Ottawa Distinguished Research Chair in Translational and AI Research in Venous Thrombosis. He is perhaps best known for pioneering the concept of clinical prediction rules: the "Wells Model for DVT" and the "Wells Model for PE" are taught and used world-wide. He has received over $30 million in peer reviewed research funding and has over 380 publications. His work has been acknowledged through a Canada Research Chair, and several lifetime achievement awards. His current interests are Cancer Associated Thrombosis and AI to ...

Professor and Head of Psychiatry, University of British Columbia

Dr. Lakshmi Yatham is Professor and Head of the UBC Department of Psychiatry, Director of the UBC Institute of Mental Health, and Regional Head of Psychiatry for Vancouver Coastal and Providence Health Care Authorities. He is also Editor-in-Chief for the Canadian Journal of Psychiatry, and President of the World Federation of Societies of Biological Psychiatry. Dr. Yatham is a world-class clinician scientist in mood disorders who has made fundamental advancements to the understanding of the neurobiology and treatment of bipolar disorder. He is a highly cited researcher and has won numerous ...

Director, Research Institute, Krembil Research Institute, Toronto Western Hospital, University Health Network

Donald Weaver combines fully the careers of a clinical neurologist, biomedical engineer and molecular chemist who develops drugs for the diseases he treats. From his very active university research programs five very active companies have been formed to continue the development and testing of drugs his laboratory has produced for Alzheimer’s disease, epilepsy, systemic amyloidosis, neuropathic pain, and other neurological diseases. Many of these drugs are well advanced and hold great promise for more effective therapy for these important conditions. For his work he has received many awards ...